Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey - (:unkn) unknown (ELSEVIER SCIENCE INC, 2018)
Keywords: NSCLC; ALK inhibitor; crizotinib